No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Arrail Group Limited is a Chinese healthcare provider that manages a network of dental clinics and hospitals. It conducts its operations primarily through two brand identities: Arrail Dental and Rytime Dental. The company delivers a comprehensive suite of dental services, including general dental care, orthodontics, and implantology. As of March 21, 2022, its extensive network consisted of 51 clinics operating under the Arrail Dental name, in addition to 54 clinics and seven hospitals functioning under the Rytime Dental brand. Headquartered in Beijing, China, the firm was founded in 1999.
www.arrailgroup.comNo one on the platform currently holds 6639.HK.
No tracked institution reports a position in 6639.HK as of their last filing.
No one on the platform has traded 6639.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.2% | — | — | — | ||
| Rev. Growth % | -3.3% | 8.9% | ||||
| Profit Margin % | 1.3% | -19.1% | ||||
| Free Cash Flow Margin % | 10.2% | 8.6% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.9B | +12.0% | $0.08 | $0.08–$0.08 | — | 1 |
| 2028 | $2.5B | +31.8% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 6639.HKArrail Group Limited | $1.83 | +4.57% | $1.0B | — |
| 0383.HKTian An Medicare Limited | $0.78 | -0.64% | $785M | — |
| 0950.HKLee's Pharmaceutical Holdings Limited | $1.14 | -0.87% | $671M | — |
| 1846.HKEuroEyes International Eye Clinic Limited | $2.30 | +0.00% | $735M | — |
| 2120.HKWenzhou Kangning Hospital Co., Ltd. | $9.30 | +0.05% | $655M | — |
| 2257.HKSirnaomics Ltd. | $3.78 | -3.69% | $412M | — |
| 2500.HKVenus Medtech (Hangzhou) Inc. | $1.17 | +6.36% | $516M | — |
Source: Financial Modeling Prep · peers by sector/industry